Instructions for Cinnarizine 25 mg 50 pills
English product name
Cinnarizin
Release form
tab 25 mg: 50 pcs
Description Cinnarizine
The tablets are round, double-convex, white or almost white in color.
1 tab.
cinnarizin 25 mg
Auxiliary substances: lactose monohydrate, wheat starch, C25 povidone, silica colloid dioxide, talc, magnesium stearate.
50 pcs - PVC/Aluminum foil blisters (1) - cardboard packs.
ATC codes
N07CA02 Cinnarizine
Clinical-pharmacological groups / Group affiliation
Calcium channel blocker with primary effect on brain vessels
Active substance
cinnarizin
Pharmacotherapy group
BICC
Pharmacological effect Cinnarizine:
Class IV calcium channel blocker with primary effect on cerebral vessels, a piperazine derivative. Improves cerebral, coronary and peripheral blood circulation. It disrupts the supply of calcium ions to smooth muscle cells. Reduces the tone of smooth arteriol muscles, reduces reactions to biogenic vasoconstrictors (adrenaline, noradrenaline, bradykinin). Reduces the excitability of the vestibular apparatus. In patients with peripheral blood circulation disorder, it improves blood supply and potentiates post-surgical hyperemia. Increases tissue resistance to hypoxia.
Testimony Cinnarizine:
- Brain circulation disorders (including residual events after stroke).
- Labyrinthine disorders (including support therapy for dizziness,
- tinnitus,
- nystagmus,
- nausea and labyrinthine vomiting).
- Motion sickness (as a preventive remedy).
- Prevention of migraine attacks.
- Ménière's disease.
- Prevention and treatment of peripheral circulation disorders - obliterating atherosclerosis,
- obliterating thrombangiit,
- Reino disease,
- diabetic angiopathy,
- acrocianosis.
Method of use, course and dosage Cinnarizine:
Individual. Take in 50 mg three times a day after eating. If necessary, treatment can be started at 1/2 dose, gradually increasing it. To achieve the optimum therapeutic effect is used continuously for several months.
- Nosology (ICD codes)
- G43
- Migraine
- G45
- Transitory cerebral ischemic attacks [attacks] and related syndromes
- H81.0
- Ménière's disease
- H81.1
- Benign paroxysmal dizziness
- H81.3
- Other peripheral dizziness
- H83.2
- Labyrinthine dysfunction
- I61
- Intracerebral hemorrhage (haemorrhagic type disorder)
- I63
- Brain infarction
- I69
- Effects of cerebrovascular disease
- I73.0
- Reynaud syndrome
- I73.1
- Clotting Thrombangitis [Berger's disease]
- I73.8
- Other specified diseases of peripheral vessels
- I73.9
- Peripheral vascular disease unspecified (including interspersed lameness, arterial spasm)
- I79.2
- Peripheral angiopathy for diseases classified in other headings (including diabetic angiopathy)
- T75.3
- Motion Motion Sickness
